WADA has released its anti-doping statistical report for 2012. It is the most detailed look at anti-doping programs released to date. What is interesting about the WADA document is that it publishes testing figures that the International Tennis Federation (ITF) has steadfastly refused to disclose for years (e.g., HGH and EPO tests).
Here's a summary of the ITF statistics for 2012:
Atypical Findings: 2 (both from urine samples)
Adverse Findings: 8 (all from urine samples)
Table F12: GC/C/IRMS (Synthetic Testosterone): 92 total; 84 in-competition (IC); 8 out-of-competition (OOC)
Table F13: EPO: 200 total; 162 IC; 38 OOC
Table F14: HGH: 124 total; 99 IC; 25 OOC
Homologous Blood Transfusion: 0
Haemaglobin Based Oxygen Carriers: 0
Table J7: Athlete Biological Passport (ABP): 39 total; 13 IC; 26 OOC
A couple of comments. These statistics show that the ITF's OOC testing program continues to be extremely weak with its minimal GC/C/IRMS, EPO, and HGH testing. It's little wonder why their OOC program doesn't catch anyone.
Also, it is interesting that the statistics indicate that the ITF is already collecting ABP samples.
Table G31 in the WADA report provides additional insight by setting out all tennis testing conducted in 2012 by anti-doping organization.
Update: In typical Miller-esque fashion, the ITF's Stuart Miller has revealed today that the ITF's bio-passport program is live. Miller states that ""in effect we are up and running" and that "It's been implemented, it's up and running, and samples can be collected."